Navigation Links
ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
Date:8/5/2010

completed, 88 subjects chose to enroll in an open-label extension study for the treatment of acute attacks. At a median of 11 months, 82 of the enrolled subjects had received open-label C1-inhibitor treatment for a total of 447 separate attacks, with the number of attacks per subject ranging from one to 57 (median 3). The median time to a response for the 447 attacks was 30 minutes, irrespective of whether a subject was given open-label treatment fewer than four times, four to nine times, or 10 times or more. The Kaplan–Meier estimate of the proportion of attacks that responded to treatment within four hours was 93 percent.

About Cinryze™ (C1 esterase inhibitor [human])

Cinryze is a highly purified, pasteurized and nanofiltered plasma-derived C1 esterase inhibitor product that has been approved by FDA for routine prophylaxis against angioedema attacks in adolescent and adult patients with HAE. C1 inhibitor therapy has been used acutely for more than 35 years in Europe in patients with C1 inhibitor deficiency.

The most common adverse reactions observed have been upper respiratory infection, sinusitis, rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials. Severe hypersensitivity reactions may occur. Thrombotic events have occurred in patients receiving high dose off-label C1 inhibitor therapy well above the approved treatment dosage regimen. Monitor patients with known risk factors for thrombotic events. With any blood or plasma derived product, there may be a risk of transmission of infectious agents, e.g. viruses and, theoretically, the CJD agent. The risk has been reduced by screening patients for prior exposure to certain virus infections and by manufacturing steps to reduce the risk of viral transmission including pasteurization and nanofiltration.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 Mauna ... the multidisciplinary confocal laser endomicroscopy platform, announced today ... Ministry of Health, Labor and Welfare ... solution, the AQ-Flex 19 miniprobe.   ... 19 miniprobe is comprised of a fiber-optic microscope ...
(Date:7/6/2015)... , July 6, 2015  Protiviti, a global consulting ... Internal Auditing around the World publication ( www.protiviti.com/iaworld ... and reported on the evolution of the internal audit ... the globe as a means to providing senior executives ... this strategic business function. The 2015 edition ...
(Date:7/6/2015)... June 29, 2015 Research ... the "Pharmaceutical Grade Sodium Chloride Market by Applications, ... report to their offering. The pharmaceutical ... CAGR of 6.9% between 2014 and 2019 in terms ... 690 KT by 2019. The report on ...
Breaking Medicine Technology:Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
... N.J., May 16, 2011 New Jersey Center for ... in the nation to treat advanced prostate cancer patients ... class known as autologous cellular immunotherapies.  PROVENGE was approved ... the treatment of men with asymptomatic or minimally symptomatic ...
... public health, and regulatory highlights for this week from the ... designed for credentialed journalists. Release dates and times for items ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) FDA News & Notes ... legal limitations. Events and Speeches for ...
Cached Medicine Technology:New Jersey Center for Prostate Cancer & Urology Among First in Nation to Treat Advanced Prostate Cancer Patients with PROVENGE 2FDA News & Notes - Week of May 16, 2011 2FDA News & Notes - Week of May 16, 2011 3
(Date:7/6/2015)... ... , ... Olive Fertility Centre is proud to announce that Olive medical director ... of the department of Family Practice. , “This award is a real honour,” says ... technology is changing so rapidly and we are also developing new models of patient-centred ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... in southern California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site ... and other serious medical conditions. Screenings are affordable and accurate and run about ...
(Date:7/6/2015)... ... ... Health care systems and genomics projects have generated massive patient data sets ... this “Big Data” to improve health and cut costs is now on the horizon, ... Health System in New York City. Physicians will have these new capabilities within two ...
(Date:7/6/2015)... ... July 06, 2015 , ... In a split second, breaking a bone can ... of having a fracture through the bone health screenings conducted by American Bone Health ... participating because our residents need this information to remain independent and strong for many ...
(Date:7/6/2015)... Los Angeles, CA (PRWEB) , ... July 06, 2015 , ... ... now offering patients the opportunity to achieve their ideal appearance through comprehensive treatment solutions. ... discuss their goals with the doctor and receive a plan that resolves each of ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:National Bone Health Screening and Awareness Day 2Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2
... Diagnostic X-rays may increase the risk of developing ... at the University of California, Berkeley,s School of Public ... with acute lymphoid leukemia (ALL) had almost twice the ... X-rays compared with children who did not have leukemia. ...
... Burton, MD, FAAP, will serve as the 2010-2011 president ... Oct. 4, at the AAP National Conference and Exhibition ... AAP is the nation,s largest pediatric organization with a ... and pediatric surgical specialists. Dr. Burton will ...
... Studies have shown a high rate of depression among ... if any. To address this issue, researchers at Rhode ... depression care protocol in home health care. The early ... the 29th Annual Meeting and Exposition of the National ...
... FRANCISCO The stresses of poverty have long been ... presented Sunday, Oct. 3, at the American Academy of ... researchers directly linked an increased unemployment rate to child ... statistics from the Bureau of Labor Statistics, and compared ...
... , FRIDAY, Oct. 1 (HealthDay News) -- ,In yet another ... healthy for the heart. The current research found that when ... of sudden cardiac death dropped by 36 percent. However, when ... day, they upped their risk of sudden cardiac death by about ...
... a mid-sized hospital were able to increase productivity and ... general technologist productivity, according to a study in the ... of Radiology ( www.jacr.org ). "Improving productivity ... may be difficult to achieve simultaneously," said C. Daniel ...
Cached Medicine News:Health News:X-rays linked to increased childhood leukemia risk 2Health News:X-rays linked to increased childhood leukemia risk 3Health News:X-rays linked to increased childhood leukemia risk 4Health News:O. Marion Burton, M.D., F.A.A.P., addresses American Academy of Pediatrics in new term as president 2Health News:Can telemedicine improve geriatric depression? 2Health News:Moderate Alcohol Use Helps Prevent Sudden Cardiac Death: Study 2Health News:Moderate Alcohol Use Helps Prevent Sudden Cardiac Death: Study 3
... to quality patient care., ,S/5 Anesthesia ... to anesthesia delivery. As part of the ... features, electronically controlled gas delivery and agent ... to create a truly integrated system. The ...
... Tegagel hydrogel wound filler and ... are amorphous hydrogel dressings specially formulated ... that has been shown to enhance ... formula meets clinical needs for management ...
... SS is a complete physician preference card ... management system for all the supply management ... preference card system combined with a broad ... entire case cart and operating suite supply ...
Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
Medicine Products: